1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To evaluate intravitreal bevacizumab (IVB) injection efficacy for the treatment of chronic, atypical, or recurrent central serous chorioretinopathy (CSC).

          Related collections

          Author and article information

          Journal
          Retina (Philadelphia, Pa.)
          Retina (Philadelphia, Pa.)
          Ovid Technologies (Wolters Kluwer Health)
          1539-2864
          0275-004X
          Jan 2019
          : 39
          : 1
          Affiliations
          [1 ] Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
          [2 ] Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam, Republic of Korea.
          Article
          10.1097/IAE.0000000000001917
          29077604

          Comments

          Comment on this article